Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William M Carroll

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2018
2017 McDonald MS diagnostic criteria: Evidence-based revisionsWilliam M Carroll
The New England Journal of Medicine|January 22, 2010
Oral therapy for multiple sclerosis--sea change or incremental step?William M Carroll
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 14, 2025
'Should natalizumab be used despite JC virus positivity? Yes'William M Carroll
The Lancet. Neurology|March 19, 2019
The global burden of neurological disordersWilliam M Carroll
Journal of the Neurological Sciences|July 19, 2017
The need for a Global Neurology AllianceWilliam M Carroll
Current Treatment Options in Neurology|September 16, 2010
Neuromyelitis opticaWilliam M Carroll, Kazuo Fujihara
Journal of the Neurological Sciences|January 17, 2025
Overcoming barriers in Global Neurological Care: A call for innovation and policy change by Ishan MZ et al: Response to Ishan MZ et al and an appreciation of the potential value of the World Federation of Neurology Needs Registry Survey 2021William M Carroll, Wolgfgang Grisold
Journal of the Neurological Sciences|September 5, 2024
World Federation of Neurology Needs Registry Survey 2021William M Carroll, Wolfgang Grisold
Neurology|August 5, 2011
Does detection of anti-AQP4 antibodies trump clinical criteria for neuromyelitis optica?Brian G Weinshenker, William M Carroll
Brain Pathology (Zurich, Switzerland)|September 2, 2014
Oligodendrocyte Lineage Cells in Chronic Demyelination of Multiple Sclerosis Optic NerveAlison Ruth Jennings, William M Carroll
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2018
2017 McDonald MS diagnostic criteria: Evidence-based revisionsWilliam M Carroll
The New England Journal of Medicine|January 22, 2010
Oral therapy for multiple sclerosis--sea change or incremental step?William M Carroll
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 14, 2025
'Should natalizumab be used despite JC virus positivity? Yes'William M Carroll
The Lancet. Neurology|March 19, 2019
The global burden of neurological disordersWilliam M Carroll
Journal of the Neurological Sciences|July 19, 2017
The need for a Global Neurology AllianceWilliam M Carroll
Current Treatment Options in Neurology|September 16, 2010
Neuromyelitis opticaWilliam M Carroll, Kazuo Fujihara
Journal of the Neurological Sciences|January 17, 2025
Overcoming barriers in Global Neurological Care: A call for innovation and policy change by Ishan MZ et al: Response to Ishan MZ et al and an appreciation of the potential value of the World Federation of Neurology Needs Registry Survey 2021William M Carroll, Wolgfgang Grisold
Journal of the Neurological Sciences|September 5, 2024
World Federation of Neurology Needs Registry Survey 2021William M Carroll, Wolfgang Grisold
Neurology|August 5, 2011
Does detection of anti-AQP4 antibodies trump clinical criteria for neuromyelitis optica?Brian G Weinshenker, William M Carroll
Brain Pathology (Zurich, Switzerland)|September 2, 2014
Oligodendrocyte Lineage Cells in Chronic Demyelination of Multiple Sclerosis Optic NerveAlison Ruth Jennings, William M Carroll
Pageof 8